TOP TIERMARKET NEWSWIRE

News & sentiment

AEON BIOPHARMA INC A (AEON) — News & AI sentiment

AEON BIOPHARMA INC A (AEON) news roundup. 4 stories in the past week, 12 over 30 days. Average 30-day sentiment is 58/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $243K and 0 sales totalling $0 — net buying of $243K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

4

avg sentiment 63.5/100

30d stories

12

avg sentiment 58/100

Insider net (90d)

$243K

1 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

AEON news in the last 24 hours, 7 days, 30 days and 90 days

How much AEON coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	AEON stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	4	63.5/100	AEON headlines →
Last 30 days	12	58/100	AEON headlines →
Last 90 days	26	47.8/100	AEON headlines →

Latest stories on AEON

Aeon Biopharma announces results from ABP-450 pilot forced degradation study

The Fly59 · neutralproduct/pr

7d ago

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Business Insider67 · bullishproduct/pr

7d ago

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

GlobeNewswire67 · bullishproduct/pr

7d ago

Aeon Biopharma initiated with a Buy at Laidlaw

The Fly61 · neutralanalyst

7d ago

Laidlaw initiates Aeon Biopharma stock coverage with buy rating

Investing.com Analyst Ratings61 · neutralanalyst

Sep 9

AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

Business Insider56 · neutralgeneral

Aug 31

AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference

GlobeNewswire56 · neutralgeneral

Aug 31

AEON Biopharma Strengthens Regulatory Team With FDA Neuroscience Veteran Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer August 25, 2026

MarketChameleon63 · neutralproduct/pr

Aug 25

Aeon Biopharma designates Paul Lee as acting chief regulatory officer

The Fly55 · neutralgeneral

Aug 24

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

StockTitan56 · neutralproduct/pr

Aug 24

AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®

StockTitan63 · neutralproduct/pr

Aug 19

H.C. Wainwright cuts Aeon Biopharma stock price target on dilution

Investing.com Analyst Ratings32 · bearishanalyst

Aug 17

Aeon Biopharma price target lowered to $1.20 from $5 at H.C. Wainwright

The Fly34 · bearishanalyst

Aug 16

AEON Biopharma Q2 Non-GAAP EPS of -$0.02

Seeking Alpha34 · bearishearnings

Aug 13

AEON Biopharma Reports Q2 Results, Advances ABP-450 Program

TipRanks56 · neutralearnings

Aug 12

AEON Biopharma, Inc. (AEON) files 8-K

SEC 8-K50 · neutralgeneral

Aug 12

AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Business Insider28 · bearishgeneral

Aug 12

AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire28 · bearishgeneral

Aug 12

AEON Biopharma regains NYSE American listing compliance after $13.6M offering

Seeking Alpha24 · bearishgeneral

Aug 3

AEON Biopharma, Inc. (AEON) files 8-K

SEC 8-K50 · neutralgeneral

Aug 3

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

Business Insider59 · neutralgeneral

Aug 3

AEON Biopharma boosts liquidity with additional share sale

TipRanks28 · bearishgeneral

Jul 23

AEON Biopharma, Inc. (AEON) files 8-K

SEC 8-K50 · neutralgeneral

Jul 23

AEON Biopharma, Inc. (AEON) files 8-K

SEC 8-K50 · neutralgeneral

Jul 15

AEON Biopharma prices $13.75M offering with milestone warrants

Seeking Alpha28 · bearishgeneral

Jul 14

Open AEON in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →